A Pilot Study of Blinatumomab in Patients With Pre B-cell Acute Lymphoblastic Leukemia (ALL) and B-cell Non-Hodgkin Lymphoma (NHL) as Post-allogeneic Stem Cell Transplant (Allo-HSCT) Remission Maintenance
Phase of Trial: Phase 0
Latest Information Update: 23 Oct 2017
At a glance
- Drugs Blinatumomab (Primary) ; Dexamethasone
- Indications Acute lymphoblastic leukaemia; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 16 Oct 2017 Status changed from not yet recruiting to recruiting.
- 15 Aug 2017 Planned initiation date changed from 1 May 2017 to 21 Aug 2017.
- 18 Apr 2017 New trial record